Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Nov;38(11):2541–2544. doi: 10.1128/aac.38.11.2541

Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.

E J Anaissie 1, R Hachem 1, N C Karyotakis 1, A Gokaslan 1, M C Dignani 1, L C Stephens 1, C K Tin-U 1
PMCID: PMC188238  PMID: 7872744

Abstract

We assessed the activities of amphotericin B deoxycholate, liposomal amphotericin B, fluconazole, and SCH 39304 against 10 strains of Trichosporon beigelii in mice with hematogenous infections. Cyclophosphamide-immunosuppressed CF1 male mice were challenged intravenously with a lethal inoculum of T. beigelii (5 x 10(6) conidia per mouse) and were assigned to different treatment groups or were left untreated. Amphotericin B deoxycholate (1 mg/kg of body weight and liposomal amphotericin B (1, 5, and 10 mg/kg) were given parenterally once daily. Escalating doses (5, 10, and 20 mg/kg/day) of fluconazole and SCH 39304 were tested. We also compared the activity of amphotericin B deoxycholate plus fluconazole (1 and 10 mg/kg/day, respectively) with that of each agent alone. Fluconazole significantly prolonged the survival of mice infected with each of the 10 strains tested. Amphotericin B deoxycholate achieved various responses, improving the outcomes in mice infected with seven of the strains. Liposomal amphotericin B was not more effective than amphotericin B deoxycholate against the two strains tested. Both fluconazole and SCH 39304 reduced the kidney fungal counts in a dose-dependent pattern, with SCH 39304 being more active than fluconazole against one of the two strains tested. The activity of the combination of amphotericin B deoxycholate plus fluconazole appeared to be superior to that of either agent alone, especially in reducing the kidney fungal burden. Fluconazole is more active than amphotericin B deoxycholate against experimental murine trichosporonosis.

Full text

PDF
2541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert M. M., Graybill J. R., Rinaldi M. G. Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination. Antimicrob Agents Chemother. 1991 Sep;35(9):1721–1725. doi: 10.1128/aac.35.9.1721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anaissie E., Bodey G. P., Kantarjian H., Ro J., Vartivarian S. E., Hopfer R., Hoy J., Rolston K. New spectrum of fungal infections in patients with cancer. Rev Infect Dis. 1989 May-Jun;11(3):369–378. doi: 10.1093/clinids/11.3.369. [DOI] [PubMed] [Google Scholar]
  3. Anaissie E., Gokaslan A., Hachem R., Rubin R., Griffin G., Robinson R., Sobel J., Bodey G. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis. 1992 Nov;15(5):781–787. doi: 10.1093/clind/15.5.781. [DOI] [PubMed] [Google Scholar]
  4. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S43–S53. doi: 10.1093/clinids/14.supplement_1.s43. [DOI] [PubMed] [Google Scholar]
  5. Arnold A. G., Gribbin B., De Leval M., Macartney F., Slack M. Trichosporon capitatum causing recurrent fungal endocarditis. Thorax. 1981 Jun;36(6):478–480. doi: 10.1136/thx.36.6.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baird D. R., Harris M., Menon R., Stoddart R. W. Systemic infection with Trichosporon capitatum in two patients with acute leukaemia. Eur J Clin Microbiol. 1985 Feb;4(1):62–64. doi: 10.1007/BF02148664. [DOI] [PubMed] [Google Scholar]
  7. Bhansali S., Karanes C., Palutke W., Crane L., Kiel R., Ratanatharathorn V. Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement. Cancer. 1986 Oct 15;58(8):1630–1632. doi: 10.1002/1097-0142(19861015)58:8<1630::aid-cncr2820580808>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  8. Brahn E., Leonard P. A. Trichosporon cutaneum endocarditis: a sequela of intravenous drug abuse. Am J Clin Pathol. 1982 Nov;78(5):792–794. doi: 10.1093/ajcp/78.5.792. [DOI] [PubMed] [Google Scholar]
  9. Focus on fungal infections: an update on diagnosis and treatment. Phoenix, Arizona, 21-22 February 1991. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S1–181. [PubMed] [Google Scholar]
  10. Gardella S., Nomdedeu B., Bombí J. A., Muñoz J., Puig de la Bellacasa J., Pumarola A., Rozman C. Fatal fungemia with arthritic involvement caused by Trichosporon beigelii in a bone marrow transplant recipient. J Infect Dis. 1985 Mar;151(3):566–566. doi: 10.1093/infdis/151.3.566. [DOI] [PubMed] [Google Scholar]
  11. Girmenia C., Micozzi A., Venditti M., Meloni G., Iori A. P., Bastianello S., Martino P. Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):752–756. doi: 10.1007/BF01972503. [DOI] [PubMed] [Google Scholar]
  12. Gokaslan A., Anaissie E. A novel murine model of disseminated trichosporonosis. Infect Immun. 1992 Aug;60(8):3339–3344. doi: 10.1128/iai.60.8.3339-3344.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gold J. W., Poston W., Mertelsmann R., Lange M., Kiehn T., Edwards F., Bernard E., Christiansen K., Armstrong D. Systemic infection with Trichosporon cutaneum in a patient with acute leukemia: report of a case. Cancer. 1981 Nov 15;48(10):2163–2167. doi: 10.1002/1097-0142(19811115)48:10<2163::aid-cncr2820481008>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  14. Graybill J. R., Williams D. M., Van Cutsem E., Drutz D. J. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):551–558. doi: 10.1093/clinids/2.4.551. [DOI] [PubMed] [Google Scholar]
  15. Guého E., de Hoog G. S., Smith M. T., Meyer S. A. DNA relatedness, taxonomy, and medical significance of Geotrichum capitatum. J Clin Microbiol. 1987 Jul;25(7):1191–1194. doi: 10.1128/jcm.25.7.1191-1194.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Haupt H. M., Merz W. G., Beschorner W. E., Vaughan W. P., Saral R. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis. 1983 Feb;147(2):199–203. doi: 10.1093/infdis/147.2.199. [DOI] [PubMed] [Google Scholar]
  17. Hoy J., Hsu K. C., Rolston K., Hopfer R. L., Luna M., Bodey G. P. Trichosporon beigelii infection: a review. Rev Infect Dis. 1986 Nov-Dec;8(6):959–967. [PubMed] [Google Scholar]
  18. Ito T., Ishikawa Y., Fujii R., Hattori T., Konno M., Kawakami S., Kosakai M. Disseminated Trichosporon capitatum infection in a patient with acute leukemia. Cancer. 1988 Feb 1;61(3):585–588. doi: 10.1002/1097-0142(19880201)61:3<585::aid-cncr2820610327>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  19. Keay S., Denning D. W., Stevens D. A. Endocarditis due to Trichosporon beigelii: in vitro susceptibility of isolates and review. Rev Infect Dis. 1991 May-Jun;13(3):383–386. doi: 10.1093/clinids/13.3.383. [DOI] [PubMed] [Google Scholar]
  20. Lowenthal R. M., Atkinson K., Challis D. R., Tucker R. G., Biggs J. C. Invasive Trichosporon cutaneum infection: an increasing problem in immunosuppressed patients. Bone Marrow Transplant. 1987 Oct;2(3):321–327. [PubMed] [Google Scholar]
  21. Martinez-Lacasa J., Maña J., Niubó R., Rufi G., Saez A., Fernández-Nogués F. Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii. Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):756–758. doi: 10.1007/BF01972504. [DOI] [PubMed] [Google Scholar]
  22. Martino P., Venditti M., Micozzi A., Morace G., Polonelli L., Mantovani M. P., Petti M. C., Burgio V. L., Santini C., Serra P. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis. 1990 Jul-Aug;12(4):570–582. doi: 10.1093/clinids/12.4.570. [DOI] [PubMed] [Google Scholar]
  23. Moreno S., Buzón L., Sánchez-Sousa A. Trichosporon capitatum fungemia and intravenous drug abuse. Rev Infect Dis. 1987 Nov-Dec;9(6):1202–1203. doi: 10.1093/clinids/9.6.1202a. [DOI] [PubMed] [Google Scholar]
  24. Murray-Leisure K. A., Aber R. C., Rowley L. J., Applebaum P. C., Wisman C. B., Pennock J. L., Pierce W. S. Disseminated Trichosporon beigelii (cutaneum) infection in an artificial heart recipient. JAMA. 1986 Dec 5;256(21):2995–2998. [PubMed] [Google Scholar]
  25. Ness M. J., Markin R. S., Wood R. P., Shaw B. W., Jr, Woods G. L. Disseminated Trichosporon beigelii infection after orthotopic liver transplantation. Am J Clin Pathol. 1989 Jul;92(1):119–123. doi: 10.1093/ajcp/92.1.119. [DOI] [PubMed] [Google Scholar]
  26. Ogata K., Tanabe Y., Iwakiri K., Ito T., Yamada T., Dan K., Nomura T. Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy. Cancer. 1990 Jun 15;65(12):2793–2795. doi: 10.1002/1097-0142(19900615)65:12<2793::aid-cncr2820651231>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  27. Polak A., Scholer H. J., Wall M. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. Chemotherapy. 1982;28(6):461–479. doi: 10.1159/000238138. [DOI] [PubMed] [Google Scholar]
  28. Reinhart H. H., Urbanski D. M., Harrington S. D., Sobel J. D. Prosthetic valve endocarditis caused by Trichosporon beigelii. Am J Med. 1988 Feb;84(2):355–358. doi: 10.1016/0002-9343(88)90440-8. [DOI] [PubMed] [Google Scholar]
  29. Schaffner A., Frick P. G. The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. J Infect Dis. 1985 May;151(5):902–910. doi: 10.1093/infdis/151.5.902. [DOI] [PubMed] [Google Scholar]
  30. Sugar A. M. Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyene-azole combination. Antimicrob Agents Chemother. 1991 Aug;35(8):1669–1671. doi: 10.1128/aac.35.8.1669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Walsh T. J., Lee J. W., Melcher G. P., Navarro E., Bacher J., Callender D., Reed K. D., Wu T., Lopez-Berestein G., Pizzo P. A. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis. 1992 Jul;166(1):121–133. doi: 10.1093/infdis/166.1.121. [DOI] [PubMed] [Google Scholar]
  32. Walsh T. J., Melcher G. P., Rinaldi M. G., Lecciones J., McGough D. A., Kelly P., Lee J., Callender D., Rubin M., Pizzo P. A. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol. 1990 Jul;28(7):1616–1622. doi: 10.1128/jcm.28.7.1616-1622.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES